Polymorphisms of interleukin-1β in Japanese patients with hepatitis B virus infection

Journal of Hepatology

Volumn 46, Issue 3, 2007, Pages 381-386

  Migita, Kiyoshi ^a   Maeda, Yumi ^a   Abiru, Seigo ^a   Nakamura, Minoru ^a   Komori, Atsumasa ^a   Miyazoe, Seiji ^b   Nakao, Kazuhiko ^b   Yatsuhashi, Hiroshi ^a   Eguchi, Katsumi ^b   Ishibashi, Hiromi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Hepatic fibrosis; Hepatitis B virus; Interleukin 1 ; Liver cirrhosis; Polymorphism

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1 RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPANESE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANDEM REPEAT; DRUG ANTAGONISM; ETHNOLOGY; GENETICS; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VIROLOGY; VIRUS GENOME;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; GENOME, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-1BETA; JAPAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN-1; RISK FACTORS;

EID: 33846610504     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.09.015     Document Type: Article

References (28)

1. Friedman S.L. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1 (2004) 98-105
2. Benyon R.C., and Arthur M.J. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21 (2001) 373-384
3. Han Y.P., Zhou L., Wang J., Xiong S., Garner W.L., French S.W., et al. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J Biol Chem 279 (2004) 4820-4828
4. Dinarello C.A. The biological properties of interleukin-1. Eur Cytokine Netw 5 (1994) 517-531
5. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412 (2001) 99
6. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
7. Pociot F., Molvig J., Wogensen L., Worsaae H., and Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22 (1992) 396-402
8. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
9. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16 (1998) 27-55
10. Louis E., Satsangi J., Roussomoustakaki M., Parkes M., Fanning G., Welsh K., et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 39 (1996) 705-710
11. Bataller R., North K.E., and Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
12. Donaldson P., Agarwal K., Craggs A., Craig W., James O., and Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48 (2001) 397-402
13. Roberts-Thomson I.C., and Butler W.J. Polymorphism, alcohol and alcoholic liver disease. J Gastroenterol Hepatol 19 (2004) 1421-1422
14. Kato N., Ji G., Wang Y., Baba M., Hoshida Y., Otsuka M., et al. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 42 (2005) 846-853
15. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
16. Mansfield J.C., Holden H., Tarlow J.K., Di Giovine F.S., McDowell T.L., Wilson A.G., et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106 (1994) 637-642
17. Zeng Z.R., Hu P.J., Hu S., Pang R.P., Chen M.H., Ng M., et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52 (2003) 1684-1689
18. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., and Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91 (2000) 865-868
19. Li D., and Friedman S.L. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14 (1999) 618-633
20. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
21. Yee L.J., Tang J., Herrera J., Kaslow R.A., and van Leeuwen D.J. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 1 (2000) 386-390
22. Xuan J., Deguchi R., Watanabe S., Ozawa H., Urano T., Ogawa Y., et al. Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J Gastroenterol l40 (2005) 796-801
23. Wang Y., Kato N., Hoshida Y., Yoshida H., Taniguchi H., Goto T., et al. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
24. Maher J.J., Lozier J.S., and Scott M.K. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol 275 4 Pt 1 (1998) G847-G853
25. Matsuoka M., Pham N.T., and Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9 (1989) 71-78
26. Hirankarn N., Kimkong I., Kummee P., Tangkijvanich P., and Poovorawan Y. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12 (2006) 776-779
27. Chen C.C., Yang S.Y., Liu C.J., Lin C.L., Liaw Y.F., Lin S.M., et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 34 (2005) 1310-1318
28. Takamatsu M., Yamauchi M., Maezawa Y., Saito S., Maeyama S., and Uchikoshi T. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 95 (2000) 1305-1311